selected publications
-
academic article
- Echinacea purpurea Fractions Represent Promising Plant-Based Anti-Inflammatory Formulations. Antioxidants. 12:1-25. 2023
- Erythrocyte-derived liposomes for the treatment of inflammatory diseases. Journal of Drug Targeting. 30:873-883. 2022
-
document
- E. purpurea alkylamide-enriched fraction as a promising plant-based anti-inflammatory formulation 2022
- Erythrocyte-derived liposomes asanti-inflammatory carriers 2022
- The anti-inflammatory activity of Echinacea purpurea extracts and its fractions involves the modulation of the p38/ERK pathway in human macrophages 2021